HOYA Co. (OTCMKTS:HOCPY - Get Free Report) was the target of a significant decline in short interest in the month of May. As of May 31st, there was short interest totalling 8,000 shares, a decline of 48.4% from the May 15th total of 15,500 shares. Approximately 0.0% of the company's shares are sold short. Based on an average trading volume of 60,900 shares, the days-to-cover ratio is presently 0.1 days.
Wall Street Analyst Weigh In
Separately, Erste Group Bank upgraded shares of HOYA from a "hold" rating to a "strong-buy" rating in a report on Friday, May 23rd.
Get Our Latest Analysis on HOYA
HOYA Stock Down 2.0%
HOYA stock traded down $2.36 during trading hours on Friday, hitting $116.62. The company had a trading volume of 20,596 shares, compared to its average volume of 36,818. The firm has a market capitalization of $40.02 billion, a P/E ratio of 29.67, a price-to-earnings-growth ratio of 2.38 and a beta of 0.91. The company has a debt-to-equity ratio of 0.02, a current ratio of 5.04 and a quick ratio of 4.35. The firm's fifty day moving average is $117.49 and its 200-day moving average is $122.01. HOYA has a fifty-two week low of $97.49 and a fifty-two week high of $148.27.
HOYA (OTCMKTS:HOCPY - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The technology company reported $0.98 earnings per share for the quarter, missing the consensus estimate of $0.99 by ($0.01). The company had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.50 billion. HOYA had a net margin of 24.17% and a return on equity of 21.34%. On average, research analysts forecast that HOYA will post 3.66 earnings per share for the current year.
About HOYA
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
See Also
Before you consider HOYA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HOYA wasn't on the list.
While HOYA currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
